{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T01:11:52Z","timestamp":1754183512381,"version":"3.41.2"},"reference-count":22,"publisher":"Tohoku University Medical Press","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2025]]},"DOI":"10.1620\/tjem.2024.j149","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T17:12:53Z","timestamp":1736961173000},"page":"311-317","source":"Crossref","is-referenced-by-count":0,"title":["The Far Negative Intercept of the Regression Formula Obtained from Repeated Measurements of BChE and Albumin Levels is Useful for Detecting Hereditary Heterozygous Butyrylcholinesterase Deficiency in Patients on Dialysis"],"prefix":"10.1620","volume":"266","author":[{"given":"Naoki","family":"Tokunaga","sequence":"first","affiliation":[{"name":"Department of Laboratory, Kawashima Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisato","family":"Shima","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Hypertension, Kamei Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Okamoto","sequence":"additional","affiliation":[{"name":"Department of Laboratory, Kawashima Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Maekawa","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Hamamatsu University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Minakuchi","sequence":"additional","affiliation":[{"name":"Department of Kidney Disease, Kawashima Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Calderon-Margalit, R., Adler, B., Abramson, J.H., Gofin, J. &amp; Kark, J.D.(2006)  Butyrylcholinesterase activity, cardiovascular risk factors, and mortality in middle-aged and elderly men and women in Jerusalem.  <i>Clin. Chem<\/i>., 52, 845-852.","DOI":"10.1373\/clinchem.2005.059857"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Carrero, J.J., Thomas, F., Nagy, K., Arogundade, F., Avesani, C.M., Chan, M., Chmielewski, M., Cordeiro, A.C., Espinosa-Cuevas, A., Fiaccadori, E., Guebre-Egziabher, F., Hand, R.K., Hung, A.M., Ikizler, T.A., Johansson, L.R.,  et al.(2018)  Global Prevalence of Protein-Energy Wasting in Kidney Disease: A Meta-analysis of Contemporary Observational Studies From the International Society of Renal Nutrition and Metabolism.  <i>J. Ren. Nutr<\/i>., 28, 380-392.","DOI":"10.1053\/j.jrn.2018.08.006"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Cobo, G., Lindholm, B. &amp; Stenvinkel, P.(2018)  Chronic inflammation in end-stage renal disease and dialysis.  <i>Nephrol. Dial. Transplant<\/i>., 33, iii35-iii40.","DOI":"10.1093\/ndt\/gfy175"},{"key":"4","unstructured":"Das, U.N.(2007)  Acetylcholinesterase and butyrylcholinesterase as possible markers of low-grade systemic inflammation.  <i>Med. Sci. Monit<\/i>., 13, RA214-221."},{"key":"5","doi-asserted-by":"crossref","unstructured":"Fukushi, K., Okamoto, T., Ozaki, Y., Ozaki, K., Sasaki, D., Miura, Y., Okuyama, Y., Tanaka, Y., Imanishi, K., Hatakeyama, S., Saitoh, F. &amp; Ohyama, C.(2022)  Butyrylcholinesterase level as an independent prognostic factor for overall survival in patients on maintenance hemodialysis: a single-center retrospective study.  <i>Clin. Exp. Nephrol<\/i>., 26, 190-197.","DOI":"10.1007\/s10157-021-02140-6"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Garcia, S.C., Wyse, A.T., Valentini, J., Roehrs, M., Moro, A.M., Paniz, C., Schmitt, G., Grotto, D. &amp; Pomblum, V.J.(2008) Butyrylcholinesterase activity is reduced in haemodialysis patients: is there association with hyperhomocysteinemia and\/or oxidative stress? <i>Clin. Biochem.<\/i>, 41, 474-479.","DOI":"10.1016\/j.clinbiochem.2008.01.005"},{"key":"7","doi-asserted-by":"crossref","unstructured":"G\u00e4tke, M.R., Bundgaard, J.R. &amp; Viby-Mogensen, J.(2007)  Two novel mutations in the BCHE gene in patients with prolonged duration of action of mivacurium or succinylcholine during anaesthesia. <i>Pharmacogenet Genomics<\/i>, 17, 995-999.","DOI":"10.1097\/FPC.0b013e3282f06646"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Hubbard, R.E., O\u2019Mahony, M.S., Calver, B.L. &amp; Woodhouse, K.W.(2008)  Plasma esterases and inflammation in ageing and frailty.  <i>Eur. J. Clin. Pharmacol<\/i>., 64, 895-900.","DOI":"10.1007\/s00228-008-0499-1"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Ichihara, K., Yomamoto, Y., Hotta, T., Hosogaya, S., Miyachi, H., Itoh, Y., Ishibashi, M. &amp; Kang, D.; Committee on Common Reference Intervals, Japan Society of Clinical Chemistry.(2016)  Collaborative derivation of reference intervals for major clinical laboratory tests in Japan.  <i>Ann. Clin. Biochem<\/i>., 53, 347-356.","DOI":"10.1177\/0004563215608875"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Ikizler, T.A.(2013)  A patient with CKD and poor nutritional status.  <i>Clin. J. Am. Soc. Nephrol<\/i>., 8, 2174-2182.","DOI":"10.2215\/CJN.04630513"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Ikizler, T.A., Flakoll, P.J., Parker, R.A. &amp; Hakim, R.M.(1994)  Amino acid and albumin losses during hemodialysis.  <i>Kidney Int<\/i>., 46, 830-837.","DOI":"10.1038\/ki.1994.339"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Lampon, N., Hermida-Cadahia, E.F., Riveiro, A. &amp; Tutor, J.C.(2012)  Association between butyrylcholinesterase activity and low-grade systemic inflammation.  <i>Ann. Hepatol<\/i>., 11, 356-363.","DOI":"10.1016\/S1665-2681(19)30932-9"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Lockridge, O.(2015)  Review of human butyrylcholinesterase structure, function, genetic variants, history of use in the clinic, and potential therapeutic uses.  <i>Pharmacol. Ther<\/i>., 148, 34-46.","DOI":"10.1016\/j.pharmthera.2014.11.011"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Maekawa, M., Sudo, K., Dey, D.C., Ishikawa, J., Izumi, M., Kotani, K. &amp; Kanno, T.(1997)  Genetic mutations of butyrylcholine esterase identified from phenotypic abnormalities in Japan.  <i>Clin. Chem<\/i>., 43, 924-929.","DOI":"10.1093\/clinchem\/43.6.924"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Masson, P.(1989)  A naturally occurring molecular form of human plasma cholinesterase is an albumin conjugate.  <i>Biochim. Biophys. Acta<\/i>, 998, 258-266.","DOI":"10.1016\/0167-4838(89)90282-3"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Okamoto, T., Hatakeyama, S., Tanaka, Y., Imanishi, K., Takashima, T., Saitoh, F., Koie, T., Suzuki, T. &amp; Ohyama, C.(2018)  Butyrylcholinesterase level as an independent factor of erythropoiesis-stimulating agent resistance in patients on maintenance hemodialysis: a single-center cross-sectional study.  <i>Clin. Exp. Nephrol<\/i>., 22, 1174-1181.","DOI":"10.1007\/s10157-018-1569-z"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Patocka, J., Kuca, K. &amp; Jun, D.(2004) Acetylcholinesterase and butyrylcholinesterase\u2014important enzymes of human body. <i>Acta Medica<\/i> (<i>Hradec Kralove<\/i>), 47, 215-228.","DOI":"10.14712\/18059694.2018.95"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Santarpia, L., Grandone, I., Contaldo, F. &amp; Pasanisi, F.(2013)  Butyrylcholinesterase as a prognostic marker: a review of the literature.  <i>J. Cachexia Sarcopenia Muscle<\/i>, 4, 31-39.","DOI":"10.1007\/s13539-012-0083-5"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Stojanov, M.D., Jovicic, D.M., Djuric, S.P., Konjevic, M.M., Todorovic, Z.M. &amp; Prostran, M.S.(2009)  Butyrylcholinesterase activity and mortality risk in hemodialysis patients: comparison to hsCRP and albumin.  <i>Clin. Biochem<\/i>., 42, 22-26.","DOI":"10.1016\/j.clinbiochem.2008.10.010"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Sulzgruber, P., Koller, L., Reiberger, T., El-Hamid, F., Forster, S., Rothgerber, D.J., Goliasch, G., Wojta, J. &amp; Niessner, A.(2015)  Butyrylcholinesterase predicts cardiac mortality in young patients with acute coronary syndrome.  <i>PLoS One<\/i>, 10, e0123948.","DOI":"10.1371\/journal.pone.0123948"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Tokunaga, N., Shima, H., Okamoto, T., Maekawa, M. &amp; Minakuchi, J.(2024)  The First-Known Case of Hereditary Heterozygous Butyrylcholinesterase Deficiency in a Patient on Dialysis.  <i>Cureus<\/i>, 16, e53153.","DOI":"10.7759\/cureus.53153"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Yeun, J.Y. &amp; Kaysen, G.A.(1998)  Factors influencing serum albumin in dialysis patients.  <i>Am. J. Kidney Dis<\/i>., 32, S118-125.","DOI":"10.1016\/S0272-6386(98)70174-X"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/266\/4\/266_2024.J149\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T04:01:49Z","timestamp":1754107309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/266\/4\/266_2024.J149\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.2024.j149","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"type":"print","value":"0040-8727"},{"type":"electronic","value":"1349-3329"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"2024.J149"}}